ASD Acronym,Designation,Title of Standard,Abstract,Link,Published Status
ICH,ICH E1,E1 The Extent of Population Exposure to Assess Clinical Safety for Drugs Intended for Long-Term Treatment of Non-Life Threatening Conditions,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=E1,
ICH,ICH E10,E10 Choice of Control Group and Related Issues in Clinical Trials,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=E10,
ICH,ICH E11(R1),E11(R1) Clinical Investigation of Medicinal Products in the Pediatric Population: Guideline and Addendum,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=E11(R1),
ICH,ICH E11A,E11A EWG Paediatric Extrapolation,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=E11A,
ICH,ICH E12,E12 Principles for Clinical Evaluation of New Antihypertensive Drugs,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=E12,
ICH,ICH E14,E14 The Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=E14,
ICH,ICH E14,E14 Q&As (R3) Questions & Answers: The Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=E14,
ICH,ICH E14/S7B,E14/S7B IWG Questions & Answers: Clinical and Nonclinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=E14/S7B,
ICH,ICH E14/S7B IWG, E14/S7B IWG Questions and Answers: Clinical and Nonclinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential Discussion Group,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=E14,
ICH,ICH E15,"E15 Definitions for Genomic Biomarkers, Pharmacogenomics, Pharmacogenetics, Genomic Data and Sample Coding Categories","""Visit the link for more information""",https://www.ich.org/search?searchPhrase=E15,
ICH,ICH E16,"E16 Biomarkers Related to Drug or Biotechnology Product Development: Context, Structure and Format of Qualification Submissions","""Visit the link for more information""",https://www.ich.org/search?searchPhrase=E16,
ICH,ICH E17,E17 General principles for planning and design of Multi-Regional Clinical Trials,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=E17,
ICH,ICH E18,E18 Genomic Sampling and Management of Genomic Data,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=E18,
ICH,ICH E19,E19 A Selective Approach to Safety Data Collection in Specific Late-Stage Pre-approval or Post-Approval Clinical Trials,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=E19,
ICH,ICH E20,E20 EWG Adaptive Clinical Trials,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=E20,
ICH,ICH E2A,E2A Clinical Safety Data Management: Definitions and Standards for Expedited Reporting,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=E2A,
ICH,ICH E2B(R3),E2B(R3) Clinical Safety Data Management: Data Elements for Transmission of Individual Case Safety Reports (ICSRs),"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=E2B(R3),
ICH,ICH E2B(R3),E2B(R3) EWG/IWG Electronic Transmission of Individual Case Safety Reports (ICSRs),"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=E2B(R3),
ICH,ICH E2B(R3),E2B(R3) Q&As Clinical Safety Data Management: Data Elements for Transmission of Individual Case Safety Reports,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=E2B(R3),
ICH,ICH E2C(R2),E2C(R2) Periodic Benefit-Risk Evaluation Report,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=E2C(R2),
ICH,ICH E2C(R2),E2C(R2) Q&As Questions & Answers: Periodic Benefit-Risk Evaluation Report,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=E2C(R2),
ICH,ICH E2D,E2D Post-Approval Safety Data Management: Definitions and Standards for Expedited Reporting,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=E2D,
ICH,ICH E2D(R1),E2D(R1) EWG Post-Approval Safety Data: Definitions and Standards for Management and Reporting of Individual Case Safety Reports,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=E2D(R1),
ICH,ICH E2E,E2E Pharmacovigilance Planning,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=E2E,
ICH,ICH E2F,E2F Development Safety Update Report,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=E2F,
ICH,ICH E3,E3 Structure and Content of Clinical Study Reports,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=E3,
ICH,ICH E3,E3 Q&As (R1) Questions & Answers: Structure and Content of Clinical Study Reports,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=E3,
ICH,ICH E4,E4 Dose-Response Information to Support Drug Registration,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=E4,
ICH,ICH E5,E5 Q&As (R1) Questions & Answers: Ethnic Factors in the Acceptability of Foreign Clinical Data,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=E5,
ICH,ICH E5(R1),E5(R1) Ethnic Factors in the Acceptability of Foreign Clinical Data,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=E5(R1),
ICH,ICH E6(R2),E6(R2) Good Clinical Practice (GCP),"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=E6(R2),
ICH,ICH E6(R3),E6(R3) Annex 2 Sub-group,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=E6(R3),
ICH,ICH E6(R3),E6(R3) EWG Good Clinical Practice (GCP),"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=E6(R3),
ICH,ICH E7,E7 Studies in Support of Special Populations: Geriatrics,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=E7,
ICH,ICH E7,E7 Q&As Questions & Answers: Studies in Support of Special Populations : Geriatrics,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=E7,
ICH,ICH E8,E8 General Considerations for Clinical Trials,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=E8,
ICH,ICH E8(R1),E8(R1)  General Considerations for Clinical Studies,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=E8(R1),
ICH,ICH E9,E9 Statistical Principles for Clinical Trials,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=E9,
ICH,ICH E9(R1),E9(R1) Addendum: Statistical Principles for Clinical Trials,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=E9(R1),
ICH,ICH M1,M1 MedDRA - Medical Dictionary for Regulatory Activities,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=M1,
ICH,ICH M1,M1 PtC WG MedDRA Points to Consider,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=M1,
ICH,ICH M10,M10 Bioanalytical Method Validation and Study Sample Analysis,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=M10,
ICH,ICH M10,M10 Q&As Questions and Answers: Bioanalytical Method Validation and Study Sample Analysis,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=M10,
ICH,ICH M11,M11 EWG Clinical electronic Structured Harmonised Protocol (CeSHarP),"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=M11,
ICH,ICH M12,M12 Drug Interaction Studies ,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=M12,
ICH,ICH M12,M12 Q&As Question and Answers: Drug Interactions Studies,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=M12,
ICH,ICH M13A,M13A EWG Bioequivalence for Immediate-Release Solid Oral Dosage Forms,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=M13A,
ICH,ICH M13A Q&As, M13A Q&As Question and Answers: Bioequivalence for Immediate-Release Solid Oral Dosage Forms,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase= M13A Q&As,
ICH,ICH M13B,M13B EWG  Bioequivalence for Immediate-Release Solid Oral Dosage Forms,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=M13B,
ICH,ICH M14,"M14 EWG General principles on plan, design, and analysis of pharmacoepidemiological studies that utilize real-world data for safety assessment of medicines","""Visit the link for more information""",https://www.ich.org/search?searchPhrase=M14,
ICH,ICH M2,M2 EWG Electronic Standards for the Transfer of Regulatory Information,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=M2,
ICH,ICH M3(R2),M3(R2) Guidance on Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=M3(R2),
ICH,ICH M3(R2),M3(R2) Q&As (R2) Questions & Answers: Guidance on Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=M3(R2),
ICH,ICH M4,M4 Q&As (R3) Questions & Answers: Organisation of the Common Technical Document for the Registration of Pharmaceuticals for Human Use,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=M4,
ICH,ICH M4(R4),M4(R4) Organisation Including the Granularity document that provides guidance on document location and paginations,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=M4(R4),
ICH,ICH M4E,M4E Q&As (R4) Questions & Answers: CTD on Efficacy,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=M4E,
ICH,ICH M4E(R2),M4E(R2) CTD on Efficacy,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=M4E(R2),
ICH,ICH M4Q,M4Q Q&As (R1) Questions & Answers: CTD on Quality,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=M4Q,
ICH,ICH M4Q(R1),M4Q(R1) IWG Quality,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=M4Q(R1),
ICH,ICH M4Q(R2),M4Q(R2) EWG Revision of M4Q(R1),"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=M4Q(R2),
ICH,ICH M4S,M4S Q&As (R2) Questions & Answers: CTD on Safety,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=M4S,
ICH,ICH M4S(R2),M4S(R2) CTD on Safety,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=M4S(R2),
ICH,ICH M5,M5 Data Elements and Standards for Drug Dictionaries,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=M5,
ICH,ICH M6,M6 Virus and Gene Therapy Vector Shedding and Transmission,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=M6,
ICH,ICH M7,M7 Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=M7,
ICH,ICH M7,M7 Sub-group Risk Assessment and Control of Nitrosamine Impurities,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=M7,
ICH,ICH M7(R1),M7(R1) Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=M7(R1),
ICH,ICH M7(R2),M7(R2) Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=M7(R2),
ICH,ICH M7(R2),M7(R2) Q&As Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=M7(R2),
ICH,ICH M7(R3),M7(R3) Maintenance EWG/IWG Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=M7(R3),
ICH,ICH M8,M8 eCTD v3.2.2 Electronic Common Technical Document (eCTD) v3.2.2,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=M8,
ICH,ICH M8,M8 eCTD v4.0 Electronic Common Technical Document (eCTD) v4.0,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=M8,
ICH,ICH M8,M8 EWG/IWG Electronic Common Technical Document (eCTD),"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=M8,
ICH,ICH M9,M9 Biopharmaceutics Classification System-based Biowaivers,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=M9,
ICH,ICH M9,M9 Q&As Q&As on Biopharmaceutics Classification System-based Biowaivers,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=M9,
ICH,ICH MIDD,MIDD DG Model-Informed Drug Development,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=MIDD,
ICH,ICH Q1/Q5C,Q1/Q5C EWG Targeted Revisions of the ICH Stability Guideline Series,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q1/Q5C,
ICH,ICH Q10,Q10 Pharmaceutical Quality System,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q10,
ICH,ICH Q11,Q11 Development and Manufacture of Drug Substances (Chemical Entities and Biotechnological/Biological Entities),"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q11,
ICH,ICH Q11,Q11 Q&As Questions & Answers: Selection and Justification of Starting Materials for the Manufacture of Drug Substances,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q11,
ICH,ICH Q12,Q12 Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q12,
ICH,ICH Q12,Q12 IWG Training on Regulatory and Technical Considerations for Pharmaceutical Product Lifecycle Management,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q12,
ICH,ICH Q13,Q13 Continuous Manufacturing of Drug Substances and Drug Products,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q13,
ICH,ICH Q13,Q13 IWG Training on Continuous Manufacturing of Drug Substances and Drug Products,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q13,
ICH,ICH Q14,Q14 Analytical Procedure Development,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q14,
ICH,ICH Q1A(R2),Q1A(R2) Stability Testing of New Drug Substances and Products,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q1A(R2),
ICH,ICH Q1B,Q1B Stability Testing : Photostability Testing of New Drug Substances and Products,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q1B,
ICH,ICH Q1C,Q1C Stability Testing for New Dosage Forms,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q1C,
ICH,ICH Q1D,Q1D Bracketing and Matrixing Designs for Stability Testing of New Drug Substances and Products,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q1D,
ICH,ICH Q1E,Q1E Evaluation of Stability Data,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q1E,
ICH,ICH Q1F,Q1F Stability Data Package for Registration Applications in Climatic Zones III and IV,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q1F,
ICH,ICH Q2(R1),Q2(R1) Validation of Analytical Procedures: Text and Methodology,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q2(R1),
ICH,ICH Q2(R2),Q2(R2) Revision of Q2(R1) Analytical Validation,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q2(R2),
ICH,ICH Q2(R2)/Q14,Q2(R2)/Q14 IWG Training on Validation of Analytical Procedures and Q14: Analytical Procedure Development,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q2(R2)/Q14,
ICH,ICH Q3A(R2),Q3A(R2) Impurities in New Drug Substances,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q3A(R2),
ICH,ICH Q3B(R2),Q3B(R2) Impurities in New Drug Products,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q3B(R2),
ICH,ICH Q3C(R10),Q3C(R10) Maintenance EWG Maintenance of the Guideline for Residual Solvents,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q3C(R10),
ICH,ICH Q3C(R7),Q3C(R7) Maintenance of the Guideline for Residual Solvents,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q3C(R7),
ICH,ICH Q3C(R8),Q3C(R8) Guideline for Residual Solvents,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q3C(R8),
ICH,ICH Q3C(R9),Q3C(R9)  Guideline for Residual Solvents,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q3C(R9),
ICH,ICH Q3D,Q3D Guideline for Elemental Impurities,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q3D,
ICH,ICH Q3D,Q3D training Implementation of Guideline for Elemental Impurities,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q3D,
ICH,ICH Q3D(R2),Q3D(R2) Guideline for Elemental Impurities,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q3D(R2),
ICH,ICH Q3D(R3),Q3D(R3) Maintenance EWG Maintenance of the Guideline for Elemental Impurities,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q3D(R3),
ICH,ICH Q3E,Q3E EWG Impurity: Assessment and Control of Extractables and Leachables for Pharmaceuticals and Biologics,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q3E,
ICH,ICH Q4A,Q4A Pharmacopoeial Harmonisation,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q4A,
ICH,ICH Q4B,Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q4B,
ICH,ICH Q4B,Q4B Annex 1(R1) Residue on Ignition/Sulphated Ash General Chapter,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q4B,
ICH,ICH Q4B,Q4B Annex 10(R1) Polyacrylamide Gel Electrophoresis General Chapter,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q4B,
ICH,ICH Q4B,Q4B Annex 11 Capillary Electrophoresis General Chapter,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q4B,
ICH,ICH Q4B,Q4B Annex 12 Analytical Sieving General Chapter,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q4B,
ICH,ICH Q4B,Q4B Annex 13 Bulk Density and Tapped Density of Powders General Chapter,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q4B,
ICH,ICH Q4B,Q4B Annex 14 Bacterial Endotoxins Test General Chapter,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q4B,
ICH,ICH Q4B,Q4B Annex 2(R1) Test for Extractable Volume of Parenteral Preparations General Chapter,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q4B,
ICH,ICH Q4B,Q4B Annex 3(R1) Test for Particulate Contamination: Sub-Visible Particles General Chapter,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q4B,
ICH,ICH Q4B,Q4B Annex 4A(R1) Microbiological Examination of Non-Sterile Products: Microbial Enumeration Tests General Chapter,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q4B,
ICH,ICH Q4B,Q4B Annex 4B(R1) Microbiological Examination of Non-Sterile Products: Tests for Specified Micro-Organisms General Chapter,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q4B,
ICH,ICH Q4B,Q4B Annex 4C(R1) Microbiological Examination of Non-Sterile Products: Acceptance Criteria for Pharmaceutical Preparations and Substances for Pharmaceutical Use General Chapter,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q4B,
ICH,ICH Q4B,Q4B Annex 5(R1) Disintegration Test General Chapter,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q4B,
ICH,ICH Q4B,Q4B Annex 6 Uniformity of Dosage Units General Chapter,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q4B,
ICH,ICH Q4B,Q4B Annex 7(R2) Dissolution Test General Chapter,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q4B,
ICH,ICH Q4B,Q4B Annex 8(R1) Sterility Test General Chapter,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q4B,
ICH,ICH Q4B,Q4B Annex 9(R1) Tablet Friability General Chapter,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q4B,
ICH,ICH Q4B,Q4B FAQs Frequently Asked Question,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q4B,
ICH,ICH Q4B(R1),Q4B(R1) Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q4B(R1),
ICH,ICH Q5A(R1),Q5A(R1) Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q5A(R1),
ICH,ICH Q5A(R2),Q5A(R2) Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q5A(R2),
ICH,ICH Q5A(R2),Q5A(R2) IWG Training on Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q5A(R2),
ICH,ICH Q5B,Q5B Analysis of the Expression Construct in Cells Used for Production of r-DNA Derived Protein Products,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q5B,
ICH,ICH Q5C,Q5C Quality of Biotechnological Products: Stability Testing of Biotechnological/Biological Products,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q5C,
ICH,ICH Q5D,Q5D Derivation and Characterisation of Cell Substrates Used for Production of Biotechnological/Biological Products,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q5D,
ICH,ICH Q5E,Q5E Comparability of Biotechnological/Biological Products Subject to Changes in their Manufacturing Process,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q5E,
ICH,ICH Q6(R1),Q6(R1) EWG Revision of the Specifications Guidelines,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q6(R1),
ICH,ICH Q6A,Q6A Specifications : Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q6A,
ICH,ICH Q6B,Q6B Specifications : Test Procedures and Acceptance Criteria for Biotechnological/Biological Products,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q6B,
ICH,ICH Q7,Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q7,
ICH,ICH Q7,Q7 Q&As Questions and Answers: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q7,
ICH,ICH Q8(R2),Q8(R2) Pharmaceutical Development,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q8(R2),
ICH,ICH Q8/9/10,Q8/9/10 Q&As (R4) Q8/Q9/Q10 - Implementation,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q8/9/10,
ICH,ICH Q9(R1),Q9(R1) Quality Risk Management,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q9(R1),
ICH,ICH Q9(R1),Q9(R1) IWG 2006-2010 Training on Quality Risk Management,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q9(R1),
ICH,ICH Q9(R1),Q9(R1) Training Group Quality Risk Management Quality Risk Management Training Group,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=Q9(R1),
ICH,ICH S10,S10 Photosafety Evaluation of Pharmaceuticals,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=S10,
ICH,ICH S11,S11 Nonclinical Safety Testing in Support of Development of Paediatric Medicines,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=S11,
ICH,ICH S12,S12 Nonclinical Biodistribution Considerations for Gene Therapy Products,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=S12,
ICH,ICH S1A,S1A Need for Carcinogenicity Studies of Pharmaceuticals,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=S1A,
ICH,ICH S1B,S1B Testing for Carcinogenicity of Pharmaceuticals,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=S1B,
ICH,ICH S1B(R1),S1B(R1)  Testing for Carcinogenicity of Pharmaceuticals,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=S1B(R1),
ICH,ICH S1B(R1),S1B(R1) IWG Training on Testing for Carcinogenicity of Pharmaceuticals,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=S1B(R1),
ICH,ICH S1C(R2),S1C(R2) Dose Selection for Carcinogenicity Studies of Pharmaceuticals,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=S1C(R2),
ICH,ICH S2(R1),S2(R1) Guidance on Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=S2(R1),
ICH,ICH S3A,S3A Note for Guidance on Toxicokinetics: The Assessment of Systemic Exposure in Toxicity Studies,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=S3A,
ICH,ICH S3A,S3A Q&As Questions and Answers: Note for Guidance on Toxicokinetics: The Assessment of Systemic Exposure - Focus on Microsampling,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=S3A,
ICH,ICH S3B,S3B Pharmacokinetics: Guidance for Repeated Dose Tissue Distribution Studies,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=S3B,
ICH,ICH S4,S4 Duration of Chronic Toxicity Testing in Animals (Rodent and Non Rodent Toxicity Testing),"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=S4,
ICH,ICH S5(R2),S5(R2) Detection of Toxicity to Reproduction for Medicinal Products & Toxicity to Male Fertility,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=S5(R2),
ICH,ICH S5(R3),S5(R3) Revision of S5 Guideline on Detection of Toxicity to Reproduction for Human Pharmaceuticals,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=S5(R3),
ICH,ICH S5(R4),S5(R4) Maintenance EWG Revision of S5 Guideline on Detection of Toxicity to Reproduction for Human Pharmaceuticals,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=S5(R4),
ICH,ICH S6(R1),S6(R1) Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=S6(R1),
ICH,ICH S7A,S7A Safety Pharmacology Studies for Human Pharmaceuticals,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=S7A,
ICH,ICH S7B,S7B The Non-Clinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=S7B,
ICH,ICH S8,S8 Immunotoxicity Studies for Human Pharmaceuticals,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=S8,
ICH,ICH S9,S9 Nonclinical Evaluation for Anticancer Pharmaceuticals,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=S9,
ICH,ICH S9,S9  Q&As Questions and Answers: Nonclinical Evaluation for Anticancer Pharmaceuticals,"""Visit the link for more information""",https://www.ich.org/search?searchPhrase=S9,
